| First Tracks Biotherapeutics, Inc. | 17,620 | US$776K | 1.7% |
| Mbx Biosciences, Inc. | 8,754 | US$577K | 1.2% |
| Ataibeckley Inc. | 79,289 | US$569K | 1.2% |
| Monopar Therapeutics Inc. | 5,200 | US$563K | 1.2% |
| Definium Therapeutics, Inc. | 12,558 | US$547K | 1.2% |
| Xencor, Inc. | 25,208 | US$509K | 1.1% |
| Zenas Biopharma, Inc. | 15,697 | US$494K | 1.1% |
| Uniqure N.v. | 11,273 | US$492K | 1.1% |
| Apogee Therapeutics, Inc. | 3,519 | US$472K | 1.0% |
| Vor Biopharma Inc. | 21,644 | US$458K | 0.99% |
| Regenxbio Inc. | 46,670 | US$452K | 0.97% |
| Lb Pharmaceuticals Inc | 10,936 | US$438K | 0.94% |
| Amylyx Pharmaceuticals, Inc. | 21,303 | US$433K | 0.93% |
| Dyne Therapeutics, Inc. | 17,087 | US$430K | 0.93% |
| Oruka Therapeutics, Inc. | 4,447 | US$429K | 0.93% |
| Nurix Therapeutics, Inc. | 18,337 | US$426K | 0.92% |
| Oric Pharmaceuticals, Inc. | 37,585 | US$416K | 0.90% |
| Gh Research Plc | 14,716 | US$413K | 0.89% |
| Sionna Therapeutics, Inc. | 8,653 | US$408K | 0.88% |
| Dianthus Therapeutics, Inc. | 3,787 | US$405K | 0.87% |
| Erasca, Inc. | 22,122 | US$402K | 0.87% |
| Jade Biosciences, Inc. | 20,261 | US$400K | 0.86% |
| Sellas Life Sciences Group, Inc. | 39,695 | US$397K | 0.86% |
| Palvella Therapeutics, Inc. | 2,856 | US$397K | 0.86% |
| Relay Therapeutics, Inc. | 20,989 | US$395K | 0.85% |
| Replimune Group, Inc. | 35,001 | US$392K | 0.84% |
| Alto Neuroscience, Inc. | 14,476 | US$392K | 0.84% |
| Bicara Therapeutics Inc. | 14,331 | US$388K | 0.84% |
| Immunome, Inc. | 16,911 | US$385K | 0.83% |
| Avalo Therapeutics, Inc. | 21,058 | US$384K | 0.83% |
| Meiragtx Holdings Plc | 32,410 | US$382K | 0.82% |
| Ideaya Biosciences, Inc. | 10,725 | US$381K | 0.82% |
| Spyglass Pharma, Inc. | 16,855 | US$380K | 0.82% |
| Kodiak Sciences Inc | 9,125 | US$379K | 0.82% |
| Revolution Medicines, Inc. | 2,020 | US$379K | 0.82% |
| Celldex Therapeutics, Inc. | 9,940 | US$378K | 0.82% |
| Spyre Therapeutics, Inc. | 3,847 | US$378K | 0.82% |
| Cullinan Therapeutics, Inc. | 22,687 | US$374K | 0.81% |
| Lexicon Pharmaceuticals, Inc. | 162K | US$374K | 0.81% |
| Xenon Pharmaceuticals Inc. | 5,966 | US$374K | 0.81% |
| Kymera Therapeutics, Inc. | 3,605 | US$373K | 0.80% |
| Biohaven Ltd. | 27,554 | US$372K | 0.80% |
| Cg Oncology, Inc. | 5,218 | US$371K | 0.80% |
| Nektar Therapeutics | 5,234 | US$370K | 0.80% |
| Enliven Therapeutics, Inc. | 6,738 | US$369K | 0.80% |
| Arcus Biosciences, Inc. | 13,060 | US$368K | 0.79% |
| Tyra Biosciences, Inc. | 11,516 | US$367K | 0.79% |
| Rezolute, Inc. | 77,705 | US$367K | 0.79% |
| Cogent Biosciences, Inc. | 9,390 | US$366K | 0.79% |
| Alumis Inc. | 12,870 | US$364K | 0.78% |
| Candel Therapeutics, Inc. | 36,310 | US$363K | 0.78% |
| Sana Biotechnology, Inc. | 116K | US$363K | 0.78% |
| Achieve Life Sciences, Inc. | 56,308 | US$361K | 0.78% |
| Olema Pharmaceuticals, Inc. | 31,490 | US$361K | 0.78% |
| Viridian Therapeutics, Inc. | 19,010 | US$360K | 0.78% |
| Praxis Precision Medicines, Inc. | 1,166 | US$359K | 0.77% |
| 4d Molecular Therapeutics, Inc. | 35,199 | US$358K | 0.77% |
| Immunovant, Inc. | 9,245 | US$357K | 0.77% |
| Vaxcyte, Inc. | 6,549 | US$354K | 0.76% |
| Disc Medicine, Inc. | 4,571 | US$352K | 0.76% |
| Rocket Pharmaceuticals, Inc. | 113K | US$352K | 0.76% |
| Generate Biomedicines, Inc. | 25,106 | US$351K | 0.76% |
| Neurogene Inc. | 10,681 | US$351K | 0.76% |
| Solid Biosciences Inc. | 43,531 | US$351K | 0.76% |
| Maze Therapeutics, Inc. | 12,924 | US$348K | 0.75% |
| Janux Therapeutics, Inc. | 22,923 | US$348K | 0.75% |
| Corvus Pharmaceuticals, Inc. | 26,054 | US$345K | 0.74% |
| Design Therapeutics, Inc. | 28,333 | US$345K | 0.74% |
| Viking Therapeutics, Inc. | 10,811 | US$343K | 0.74% |
| Edgewise Therapeutics, Inc. | 8,925 | US$343K | 0.74% |
| Aura Biosciences, Inc. | 48,490 | US$340K | 0.73% |
| Assembly Biosciences, Inc. | 13,537 | US$340K | 0.73% |
| Veradermics, Incorporated | 3,235 | US$340K | 0.73% |
| Abcellera Biologics Inc. | 59,315 | US$339K | 0.73% |
| Altimmune, Inc. | 119K | US$338K | 0.73% |
| Annexon, Inc. | 65,989 | US$336K | 0.72% |
| Mineralys Therapeutics, Inc. | 13,159 | US$336K | 0.72% |
| Scholar Rock Holding Corporation | 7,035 | US$333K | 0.72% |
| Rapport Therapeutics, Inc. | 8,094 | US$332K | 0.71% |
| Pharvaris N.v. | 10,118 | US$330K | 0.71% |
| Arvinas, Inc. | 41,004 | US$329K | 0.71% |
| Prime Medicine, Inc. | 112K | US$327K | 0.70% |
| Bridgebio Oncology Therapeutics, Inc. | 40,107 | US$324K | 0.70% |
| Climb Bio, Inc. | 27,171 | US$323K | 0.70% |
| Savara, Inc. | 59,090 | US$323K | 0.70% |
| Upstream Bio, Inc. | 50,952 | US$322K | 0.69% |
| Cytomx Therapeutics, Inc. | 103K | US$320K | 0.69% |
| Taysha Gene Therapies, Inc. | 54,433 | US$319K | 0.69% |
| Oculis Holding Ag | 28,027 | US$317K | 0.68% |
| Arbutus Biopharma Corporation | 72,962 | US$317K | 0.68% |
| Aktis Oncology, Inc. | 14,173 | US$313K | 0.67% |
| Vir Biotechnology, Inc. | 36,099 | US$313K | 0.67% |
| Allogene Therapeutics, Inc. | 164K | US$308K | 0.66% |
| Moonlake Immunotherapeutics | 16,630 | US$307K | 0.66% |
| Immix Biopharma, Inc. | 36,782 | US$306K | 0.66% |
| Prothena Corporation Plc | 37,674 | US$306K | 0.66% |
| Arrivent Biopharma, Inc. | 10,177 | US$303K | 0.65% |
| Celcuity Inc. | 3,510 | US$303K | 0.65% |
| Stoke Therapeutics, Inc. | 10,423 | US$301K | 0.65% |
| Septerna, Inc. | 8,646 | US$298K | 0.64% |